Neurogene Inc. (NGNE) Operating cash flow 2016–2025
Neurogene Inc. (NGNE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$77.2MFY2025 · since FY2016: -$30.2M → -$77.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$77.2M | -9.3% |
| FY2024 | -$70.6M | -37.3% |
| FY2023 | -$51.4M | +2.7% |
| FY2022 | -$52.8M | -11.1% |
| FY2021 | -$47.6M | -93.5% |
| FY2020 | -$24.6M | -59.6% |
| FY2019 | -$15.4M | +51.2% |
| FY2018 | -$31.6M | +29.4% |
| FY2017 | -$44.7M | -47.9% |
| FY2016 | -$30.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice